Outputs (2)

Preventing Cardiac Damage in Patients Treated for Breast Cancer and Lymphoma: The PROACT Clinical Trial (2024)
Journal Article
Austin, D., Maier, R. H., Akhter, N., Sayari, M., Ogundimu, E., Maddox, J. M., Vahabi, S., Humphreys, A. C., Graham, J., Oxenham, H., Haney, S., Cresti, N., Verrill, M., Osborne, W., Wright, K. L., Goranova, R., Bailey, J. R., Kalakonda, N., Macheta, M., Kilner, M. F., …Plummer, C. (2024). Preventing Cardiac Damage in Patients Treated for Breast Cancer and Lymphoma: The PROACT Clinical Trial. Journal of the American College of Cardiology, 6(5), 684-696. https://doi.org/10.1016/j.jaccao.2024.07.010

Background
Cardiotoxicity is a concern for cancer survivors undergoing anthracycline chemotherapy. Enalapril has been explored for its potential to mitigate cardiotoxicity in cancer patients. The dose-dependent cardiotoxicity effec... Read More about Preventing Cardiac Damage in Patients Treated for Breast Cancer and Lymphoma: The PROACT Clinical Trial.

Lack of effect of a parent‐delivered early language intervention: Evidence from a randomised controlled trial completed during COVID‐19 (2024)
Journal Article
Burgoyne, K., Hargreaves, S., Akhter, N., Cramman, H., Eerola, P., Einbeck, J., & Menzies, V. (online). Lack of effect of a parent‐delivered early language intervention: Evidence from a randomised controlled trial completed during COVID‐19. JCPP Advances, Article e12279. https://doi.org/10.1002/jcv2.12279

Background: Parents play a key role in their child's early development but evidence that parental engagement strategies are effective is unclear. The current study evaluated a parent‐delivered early language teaching programme that aimed to support c... Read More about Lack of effect of a parent‐delivered early language intervention: Evidence from a randomised controlled trial completed during COVID‐19.